Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Familial Cancer
|
October 24, 2003
Cancer prone persons. A randomized screening trial based on colonoscopy: background, design and recruitment
F Eisinger, J P Giordanella, A Brigand, et al.
Gastroenterologie Clinique Et Biologique
|
June 17, 2008
Predictive factors of the response to chemoradiotherapy in esophageal cancer
E Ressiot, L Dahan, A Liprandi, et al.
Gastroenterologie Clinique Et Biologique
|
February 26, 2010
[Use of sorafenib in patients with hepatocellular or renal carcinoma]
O Rosmorduc, C Chevreau, P Dielenseger, et al.
American Journal of Clinical Pathology
|
November 5, 1999
Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples
G M Monges, M P Mathoulin-Portier, R B Acres, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
The International Journal of Biological Markers
|
April 18, 2003
Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer
S I Gilles, S Romain, P Casellas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer
D Fallik, M Ychou, J Jacob, et al.
British Journal of Cancer
|
January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'
J Bennouna, H Perrier, B Paillot, et al.
Cancer Chemotherapy and Pharmacology
|
November 20, 2002
High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer
M Ychou, J L Raoul, F Desseigne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer
P Rougier, B Paillot, A LaPlanche, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Familial Cancer
|
October 24, 2003
Cancer prone persons. A randomized screening trial based on colonoscopy: background, design and recruitment
F Eisinger, J P Giordanella, A Brigand, et al.
Gastroenterologie Clinique Et Biologique
|
June 17, 2008
Predictive factors of the response to chemoradiotherapy in esophageal cancer
E Ressiot, L Dahan, A Liprandi, et al.
Gastroenterologie Clinique Et Biologique
|
February 26, 2010
[Use of sorafenib in patients with hepatocellular or renal carcinoma]
O Rosmorduc, C Chevreau, P Dielenseger, et al.
American Journal of Clinical Pathology
|
November 5, 1999
Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples
G M Monges, M P Mathoulin-Portier, R B Acres, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
The International Journal of Biological Markers
|
April 18, 2003
Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer
S I Gilles, S Romain, P Casellas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer
D Fallik, M Ychou, J Jacob, et al.
British Journal of Cancer
|
January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'
J Bennouna, H Perrier, B Paillot, et al.
Cancer Chemotherapy and Pharmacology
|
November 20, 2002
High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer
M Ychou, J L Raoul, F Desseigne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer
P Rougier, B Paillot, A LaPlanche, et al.
Page
of 12